Manufacturing facility for ophthalmic drugs will be established in Ingushetia

| By | Drug Manufacturing, Pharmaceutical Plant Construction
0
161

The Republic of Ingushetia intends to sign 9 agreements and contracts on cooperation with major corporations and a number of Russian entities during the 22nd St. Petersburg International Economic Forum (SPIEF).

In particular, the region plans to conclude an investment agreement with a major Indian company to organize a production facility for ophthalmic drugs in its territory. This was announced by the regional Deputy Prime Minister Igor Khranovsky, who is in charge of economic activities.

According to I. Khranovsky, during the SPIEF, the Republic plans to sign an agreement with Varthamana International Traders CJCS, which is the exclusive distributor of ophthalmic equipment and pharmaceuticals produced by Appasamy Associates and Group of companies, a major manufacturer from India, in Russia and the CIS.

“This includes a joint project on manufacturing eye drops and other ophthalmology-related drugs in the Republic of Ingushetia. The investments will reach 200 million rubles. So far, there is no such production facility in Russia,” said I. Khranovsky.